Andrew Park is currently the Associate Director, Clinical Operations Leader at Galapagos, a position they have held since 2025. Previously, Andrew served as the Site Management Lead at Alexion Pharmaceuticals, Inc. from 2020 to 2022, and as the Lead Clinical Research Associate/Clinical Site Lead at Novo Nordisk from 2017 to 2020. Andrew is also pursuing a degree at Boston University.
Location
New York City Metropolitan Area, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices